Home/Filings/8-K/0001628280-26-001781
8-K//Current report

Omada Health, Inc. 8-K

Accession 0001628280-26-001781

$OMDACIK 0001611115operating

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 9:06 AM ET

Size

176.7 KB

Accession

0001628280-26-001781

Research Summary

AI-generated summary of this filing

Updated

Omada Health Reports Preliminary Q4 and FY2025 Revenue

What Happened

  • Omada Health, Inc. announced preliminary unaudited revenue results for the fourth quarter and fiscal year ended December 31, 2025 in a press release furnished with an 8-K filed January 12, 2026.
  • The company said these results are preliminary and subject to the completion of Omada’s final closing procedures and its annual independent audit, and therefore may be adjusted.

Key Details

  • Event: Item 2.02 (Results of Operations and Financial Condition) disclosed via press release.
  • Date filed: January 12, 2026 (Current Report on Form 8-K).
  • Exhibit: Press release furnished as Exhibit 99.1 to the 8-K.
  • Signatory: Report signed by CEO Sean Duffy.
  • Status of figures: Unaudited, preliminary and subject to adjustment pending final close and audit.

Why It Matters

  • This filing gives investors an early, preliminary view of Omada’s revenue performance for Q4 and full-year 2025 ahead of audited results or a formal 10-K. Because the numbers are unaudited and may change, investors should treat them as provisional and watch for the company’s final audited results and any updated guidance. Earnings and revenue disclosures like this can influence short-term market reactions, so confirm details in the posted press release (Exhibit 99.1) and subsequent filings.